US Bill Urges Automatic Insulin Interchangeability
Representative Glenn Grothman Introduces Biosimilar Insulin Access Bill
A draft Biosimilar Insulin Access Act, intended to waive US interchangeability requirements for FDA-approved biosimilar insulins, has been introduced by representative Glenn Grothman.
